For immediate release
Chicago, IL – January 10, 2022 – Zacks.com announces the list of stocks featured on the Analysts Blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Recent actions featured in the blog include: Microsoft Corp. MSFT, UnitedHealth Group Inc. UNH and The Charles Schwab Corp. SCHW.
Here are highlights from Friday’s analyst blog:
Best Stock Reports for Microsoft, UnitedHealth and Schwab
Zacks Research Daily features the best research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Microsoft Corp., UnitedHealth Group Inc., and The Charles Schwab company. These research reports were handpicked from over 70 reports released today by our team of analysts.
You can see all today’s research reports here >>>
Actions of Microsoft outperformed the S&P 500 over the past year (+ 44.1% vs. + 24.9%), with the company benefiting from the strength of its Azure cloud platform as well as an accelerated global digital transformation.
The pursuit of remote working and the widespread adoption of the hybrid working model has fueled the growth of Teams users. Microsoft has also seen an increase in the user base of its various applications, including the Microsoft 365 suite, Dynamics, and Power Platform. However, supply chain disruptions, increased costs from Azure improvements, and fierce competition in the cloud space are likely to squeeze margins.
(You can read the full Microsoft research report here >>>)
UnitedHealth stocks have gained + 15.3% in the past three months against Zacks’ medical insurance industry gain of + 13.2%. The Zacks analyst believes that UnitedHealth saw strong growth in its Optum and UnitedHealthcare segments, which in turn drove revenue.
This dynamic should continue over the next few quarters, thanks to a strong market position, new offers, renewed agreements and the expansion of service offers. Governmental activities of the UNH also remain well positioned for growth. International trade is expected to rebound in terms of membership numbers. Sluggish business affairs due to the ongoing pandemic and increasing operating expenses, however, remain major concerns.
(You can read the full research report on UnitedHealth here >>>)
Actions of Schwab have gained + 33.8% in the past six months against the industry gain of investment banking Zacks of + 11.4%. Zacks analyst believes that inorganic growth efforts and Schwab’s initiatives to increase trading revenue will continue to drive profitability.
The strategic acquisitions have not only made Schwab a leading player in brokerage, but will also be earnings accretive. The offer of commission-free trading has also led to an increase in client assets and brokerage accounts, thus improving trading income. Persistent near zero interest rates with no chance of a near-term hike and steadily rising operating expenses are some of the main headwinds, however.
(You can read the full research report on Schwab here >>>)
Other notable reports we feature today include NVIDIA Corp. (NVDA) and Diageo plc (DEO).
Zacks names “best single choice to overtake”
Among thousands of stocks, 5 Zacks pundits each chose their favorite to soar + 100% or more in the coming months. Of these 5, research director Sheraz Mian chooses one to have the most explosive advantage of all.
As one investor put it, “Cure and prevent hundreds of diseases… what should this market be worth? This company could compete with or surpass other recent Zacks stocks which are expected to double as Boston Beer Company which climbed + 143.0% in just over 9 months and NVIDIA which climbed + 175.9% in one. year.
Free: see our best stock and 4 finalists >>
Zacks investment research
800-767-3771 ext 9339
Past performance is no guarantee of future results. The potential for loss is inherent in any investment. This material is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether an investment is suitable for a particular investor. It should not be assumed that any investment in any identified and described securities, companies, sectors or markets was or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or securities asset management activities. These returns come from hypothetical portfolios composed of stocks with a Zacks rank = 1 that have been rebalanced monthly without any transaction costs. These are not the returns of actual equity portfolios. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for more information on the performance numbers displayed in this press release.
Zacks’ top picks for leveraging artificial intelligence
By 2021, this world-changing technology is expected to generate $ 327.5 billion in revenue. Now Shark Tank star and billionaire investor Mark Cuban has said AI will create “the world’s first trillionaires.” Zacks’ Urgent Special Report Reveals 3 AI Choices Investors Need To Know Today.
See 3 artificial intelligence stocks with extreme upside potential >>
Click to get this free report
Microsoft Corporation (MSFT): Free Stock Analysis Report
UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report
The Charles Schwab Corporation (SCHW): Free Stock Analysis Report
To read this article on Zacks.com, click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.